Analysis Sumitomo Seika Chemicals Company, Limited. (4008)
6/4/2024
Analysis of Sumitomo Seika Chemicals Company, Limited. (4008)
Sumitomo Seika Chemicals Company, Limited (symbol: 4008) has been showing some interesting trends in the recent days:1. **Price Movement**: The stock price has been fluctuating between 5060 and 5110 in the past few days, with the highest price recorded on 2024-06-03 at 5160.
2. **Technical Indicators**:
- **RSI Indicator**: The Relative Strength Index (RSI) has been hovering around 50-55, indicating a neutral stance in terms of momentum.
- **MACD Indicator**: The Moving Average Convergence Divergence (MACD) has shown some fluctuations, with the MACD line crossing above the signal line on some days, suggesting potential shifts in momentum.
- **Moving Averages**: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been relatively close to each other, indicating a stable trend.
3. **Overall Analysis**:
- The stock seems to be trading in a range-bound pattern, with no clear trend direction.
- Traders may look for potential breakout points above 5160 or below 5060 to determine the next significant price movement.
- It would be advisable to monitor the technical indicators closely for any signs of a trend reversal or continuation.
Please note that this analysis is based on historical data and does not guarantee future performance. It is always recommended to conduct thorough research and consult with a financial advisor before making any investment decisions.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 9.7%
- The past 5 years compound annual growth rate (CAGR) is 20.1%
It appears that the company has experienced a higher growth rate in the past compared to the estimates for the future. However, the next year and the next 5 years are expected to show a stronger growth trend compared to the current period. It's important to note that these are analyst estimates and actual performance may vary.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast above the current price. However, there is a wide range of forecasts, from a low of $164 to a high of $275, indicating some uncertainty in the market.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, the quarter ending on August 1, 2024, had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown positive returns on assets and equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage held by institutions. The stock has a beta of 1.264 and has experienced a moderate change in its fifty-two week range.
Valuation metrics show a relatively high PEG ratio and price-to-book ratio. The company's market capitalization and enterprise value are substantial, with moderate price-to-sales and enterprise-to-EBITDA ratios.
The stock price summary includes moving averages, fifty-two week high and low prices, and beta value, providing insights into the stock's performance and volatility.
Lastly, dividends and splits information reveal details about dividend rates, payout ratios, and historical split factors for the company's stock.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales have been increasing steadily over the past four years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, ranging from around 38% to 44% over the years.
3. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been increasing annually, with a significant rise from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
6. The company has been able to maintain a healthy EBITDA margin, indicating efficient operational performance.
7. Despite fluctuations in certain expenses and income components, the overall financial performance of the company seems to be positive and improving.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with cash and cash equivalents showing fluctuations.
3. Non-current assets consist mainly of investments and advances, which have been increasing steadily.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown variations, with retained earnings being a significant component.
6. The company has been relying on a mix of short-term and long-term debt to finance its operations.
7. The provision for risks and charges has been relatively stable over the years.
8. Machinery, furniture, and equipment form a substantial part of the non-current assets.
9. The company has been investing in leases and land improvements as part of its non-current assets.
10. Overall, the financial health of the company seems stable, with a positive trend in assets and shareholders' equity.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, long-term debt issuance, and payments, with significant fluctuations in values.
6. Investing activities indicate a mix of acquisitions, investments, and capital expenditures, with varying levels of cash flow.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in key financial metrics over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is also an increase from the EPS of $1.35 in the same quarter last year.
3. Looking at the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This is a growth from the EPS of $5.67 in the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This forecast indicates a potential increase from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, showing growth both in the short term and the long term.
MACD of 4008
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
